ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,662 | -29.5% | 21,613 | -14.8% | 0.00% | – |
| Q2 2023 | $335,780 | +0.4% | 25,361 | +3.2% | 0.00% | – |
| Q1 2023 | $334,370 | +2301.2% | 24,568 | +3345.7% | 0.00% | – |
| Q4 2022 | $13,925 | -66.8% | 713 | -67.9% | 0.00% | – |
| Q3 2022 | $42,000 | -17.6% | 2,224 | -9.0% | 0.00% | – |
| Q2 2022 | $51,000 | -42.7% | 2,445 | -12.7% | 0.00% | – |
| Q1 2022 | $89,000 | -77.2% | 2,802 | -66.5% | 0.00% | – |
| Q4 2021 | $390,000 | -75.9% | 8,357 | -86.0% | 0.00% | – |
| Q3 2021 | $1,617,000 | +32240.0% | 59,901 | +27631.9% | 0.00% | – |
| Q2 2021 | $5,000 | -92.2% | 216 | -88.5% | 0.00% | – |
| Q1 2021 | $64,000 | -75.8% | 1,874 | -76.0% | 0.00% | – |
| Q4 2020 | $264,000 | +35.4% | 7,811 | -1.2% | 0.00% | – |
| Q3 2020 | $195,000 | – | 7,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |